Company intelligence / Profile preview
Oryx Isotopes
Dammam, Eastern Province, Saudi Arabiaoryxisotopes.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Oryx Isotopes is a GMP- and ISO9001-certified radiopharmaceutical manufacturer established in 2021 in Dammam, Saudi Arabia, supplying diagnostic and therapeutic radioisotopes in Saudi Arabia and GCC countries. It has a strategic manufacturing and distribution partnership with Life Molecular Imaging for the PET tracer Florbetaben (18F) to support amyloid-PET imaging for Alzheimer's disease and other cognitive disorders across Saudi Arabia and the broader MENA region.[2][3][5][8]
- Therapeutic areas
- OncologyNeurology
- Modalities
- RadiopharmaceuticalRadiopharmaceutical (diagnostic)Radiopharmaceutical (therapeutic)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Life Molecular Imaging
Beyond the preview
Go deeper on Oryx Isotopes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oryx Isotopes.